Potential toxicity benefit and inter-fraction robustness of proton arc therapy compared to IMPT and VMAT for nasopharyngeal cancer patients

To ensure we keep this website safe, please can you confirm you are a human by ticking the box below.

If you are unable to complete the above request please contact us using the below link, providing a screenshot of your experience.